Home / Publications / Molecular mechanism of interactions between MMP-2 and its oligopeptide-based inhibitors

Molecular mechanism of interactions between MMP-2 and its oligopeptide-based inhibitors

2
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Khrenova M. G. et al. Molecular mechanism of interactions between MMP-2 and its oligopeptide-based inhibitors // Mendeleev Communications. 2017. Vol. 27. No. 2. pp. 157-159.
GOST all authors (up to 50) Copy
Khrenova M. G., Solovyev I. D., Lapshin G. D., Savitsky A. P. Molecular mechanism of interactions between MMP-2 and its oligopeptide-based inhibitors // Mendeleev Communications. 2017. Vol. 27. No. 2. pp. 157-159.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2017.03.017
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.03.017
TI - Molecular mechanism of interactions between MMP-2 and its oligopeptide-based inhibitors
T2 - Mendeleev Communications
AU - Khrenova, Mariya Grigor'evna
AU - Solovyev, Ilya Dmitrievich
AU - Lapshin, Grigory D
AU - Savitsky, Alexander Pavlovich
PY - 2017
DA - 2017/02/27
PB - Mendeleev Communications
SP - 157-159
IS - 2
VL - 27
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2017_Khrenova,
author = {Mariya Grigor'evna Khrenova and Ilya Dmitrievich Solovyev and Grigory D Lapshin and Alexander Pavlovich Savitsky},
title = {Molecular mechanism of interactions between MMP-2 and its oligopeptide-based inhibitors},
journal = {Mendeleev Communications},
year = {2017},
volume = {27},
publisher = {Mendeleev Communications},
month = {Feb},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.03.017},
number = {2},
pages = {157--159},
doi = {10.1016/j.mencom.2017.03.017}
}
MLA
Cite this
MLA Copy
Khrenova, Mariya Grigor'evna, et al. “Molecular mechanism of interactions between MMP-2 and its oligopeptide-based inhibitors.” Mendeleev Communications, vol. 27, no. 2, Feb. 2017, pp. 157-159. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.03.017.

Abstract

Taking matrix metalloproteinase MMP-2 as an example, we demonstrate that the rational design of oligopeptide-based inhibitors by molecular modeling should involve both a study of interactions in the active sites of the target enzyme and the conformational dynamics of the oligopeptide in solution.

References

1.
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke R.E., Libert C.
Nature Reviews Drug Discovery, 2014
2.
Matrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff C.E., Matrisian L.M.
Nature Reviews Molecular Cell Biology, 2002
3.
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall C.M., López-Otín C.
Nature Reviews Cancer, 2002
4.
Peptide-Based Selective Inhibitors of Matrix Metalloproteinase-Mediated Activities
Ndinguri M., Bhowmick M., Tokmina-Roszyk D., Robichaud T., Fields G.
Molecules, 2012
6.
Structural Basis for Matrix Metalloproteinase-2 (MMP-2)-selective Inhibitory Action of β-Amyloid Precursor Protein-derived Inhibitor
Hashimoto H., Takeuchi T., Komatsu K., Miyazaki K., Sato M., Higashi S.
Journal of Biological Chemistry, 2011
7.
Mechanism of proteolysis in matrix metalloproteinase-2 revealed by QM/MM modeling
Vasilevskaya T., Khrenova M.G., Nemukhin A.V., Thiel W.
Journal of Computational Chemistry, 2015
8.
Catalytic Mechanism of Matrix Metalloproteinases:  Two-Layered ONIOM Study
10.
Methodological aspects of QM/MM calculations: A case study on matrix metalloproteinase-2
Vasilevskaya T., Khrenova M.G., Nemukhin A.V., Thiel W.
Journal of Computational Chemistry, 2016
12.
Exploration of the zinc finger motif in controlling activity of matrix metalloproteinases
Khrenova M.G., Savitsky A.P., Topol I.A., Nemukhin A.V.
Journal of Physical Chemistry B, 2014
13.
Computational characterization of ketone-ketal transformations at the active site of matrix metalloproteinases
Khrenova M.G., Nemukhin A.V., Savitsky A.P.
Journal of Physical Chemistry B, 2014
14.
Khrenova M.G., Solovyev I.D., Azev V.N., Lapshin G.D., Savitsky A.P.
Mendeleev Communications, 2016
15.
A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor
Miyazaki K., Hasegawa M., Funahashi K., Umeda M.
Nature, 1993
16.
Continuously recording fluorescent assays optimized for five human matrix metalloproteinases
Netzel-Arnett S., Mallya S.K., Nagase H., Birkedal-Hansen H., Van Wart H.E.
Analytical Biochemistry, 1991
17.
Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant.
Murphy G., Nguyen Q., Cockett M.I., Atkinson S.J., Allan J.A., Knight C.G., Willenbrock F., Docherty A.J.
Journal of Biological Chemistry, 1994
18.
10.1016/j.mencom.2017.03.017_bib0090
Voevodin
Otkrytye Sistemy, 2012